Concepedia

Michael Amatangelo

MA

31

Publications

3K

Citations

21

H-Index

2005

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Switzerland)

Emory University

Dana-Farber Cancer Institute

Institut Català d'Oncologia

Michael Amatangelo is an author at Bristol-Myers Squibb (United States) specializing in medicine, radiation oncology, and cell biology.

Top concepts

Publications per year

2005–2024

31

Publications

31

Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers

Benjamin G. Bitler, Katherine M. Aird, Azat Garipov et al. · Nature Medicine · 2015 · 660 citations · Full text

, , +10

Enasidenib induces acute myeloid leukemia cell differentiation to promote clinical response

Michael Amatangelo, Lynn Quek, Alan H. Shih et al. · Blood · 2017 · 346 citations · Full text

Preparation of Extracellular Matrices Produced by Cultured and Primary Fibroblasts

Janusz Franco‐Barraza, Dorothy A. Beacham, Michael Amatangelo et al. · Current Protocols in Cell Biology · 2016 · 287 citations · Full text

Stroma-Derived Three-Dimensional Matrices Are Necessary and Sufficient to Promote Desmoplastic Differentiation of Normal Fibroblasts

Michael Amatangelo, Daniela Bassi, Andres J. Klein–Szanto et al. · American Journal Of Pathology · 2005 · 238 citations · Full text

, , +10

Rate of CRL4CRBN substrate Ikaros and Aiolos degradation underlies differential activity of lenalidomide and pomalidomide in multiple myeloma cells by regulation of c-Myc and IRF4

Chad C. Bjorklund, Ling Lu, Jian Kang et al. · Blood Cancer Journal · 2015 · 211 citations · Full text

Rows per page

1–5 of 31